- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Doximity Insider Sells Over $58,000 in Shares
Siddharth Sitaram, a Doximity insider, sold 2,319 shares of the company's stock.
Mar. 13, 2026 at 7:09pm by Ben Kaplan
Got story updates? Submit your updates here. ›
Siddharth Sitaram, an insider at Doximity, Inc. (NYSE:DOCS), sold 2,319 shares of the company's stock on March 10th. The shares were sold at an average price of $25.37, resulting in a total transaction value of $58,833.03. Following the sale, Sitaram still directly owns 84,132 shares in the company, valued at $2,134,428.84.
Why it matters
Insider trading activity can provide insights into a company's performance and the sentiment of its leadership. This sale by a Doximity insider may signal potential concerns or a desire to diversify holdings, though the reasons behind the transaction are not explicitly stated.
The details
Siddharth Sitaram, a Doximity insider, sold 2,319 shares of the company's stock on March 10th. The shares were sold at an average price of $25.37, resulting in a total transaction value of $58,833.03. This sale represents a 2.68% decrease in Sitaram's ownership of Doximity stock.
- The shares were sold on Tuesday, March 10th.
The players
Siddharth Sitaram
A Doximity insider who sold 2,319 shares of the company's stock.
Doximity, Inc.
A digital professional network and communications platform designed primarily for clinicians, headquartered in San Francisco.
The takeaway
This insider sale by a Doximity executive may raise questions about the company's performance or the individual's personal financial considerations, though the specific reasons are not disclosed. Investors will likely continue to monitor Doximity's stock and any future insider trading activity.
San Francisco top stories
San Francisco events
Mar. 13, 2026
Golden State Warriors vs. Minnesota TimberwolvesMar. 13, 2026
Sugar SammyMar. 13, 2026
Sam Smith - To Be Free: San Francisco 3/13




